» Articles » PMID: 33652639

Identification of Potential HCV Inhibitors Based on the Interaction of Epigallocatechin-3-Gallate with Viral Envelope Proteins

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Mar 3
PMID 33652639
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C is affecting millions of people around the globe annually, which leads to death in very high numbers. After many years of research, hepatitis C virus (HCV) remains a serious threat to the human population and needs proper management. The in silico approach in the drug discovery process is an efficient method in identifying inhibitors for various diseases. In our study, the interaction between Epigallocatechin-3-gallate, a component of green tea, and envelope glycoprotein E2 of HCV is evaluated. Epigallocatechin-3-gallate is the most promising polyphenol approved through cell culture analysis that can inhibit the entry of HCV. Therefore, various in silico techniques have been employed to find out other potential inhibitors that can behave as EGCG. Thus, the homology modelling of E2 protein was performed. The potential lead molecules were predicted using ligand-based as well as structure-based virtual screening methods. The compounds obtained were then screened through PyRx. The drugs obtained were ranked based on their binding affinities. Furthermore, the docking of the topmost drugs was performed by AutoDock Vina, while its 2D interactions were plotted in LigPlot+. The lead compound mms02387687 (2-[[5-[(4-ethylphenoxy) methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl] sulfanyl]-N-[3(trifluoromethyl) phenyl] acetamide) was ranked on top, and we believe it can serve as a drug against HCV in the future, owing to experimental validation.

Citing Articles

Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential.

Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A Molecules. 2025; 30(3).

PMID: 39942757 PMC: 11821029. DOI: 10.3390/molecules30030654.


Comprehensive Review of EGCG Modification: Esterification Methods and Their Impacts on Biological Activities.

Zhuang Y, Quan W, Wang X, Cheng Y, Jiao Y Foods. 2024; 13(8).

PMID: 38672904 PMC: 11048832. DOI: 10.3390/foods13081232.


The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma.

Li D, Cao D, Cui Y, Sun Y, Jiang J, Cao X Front Pharmacol. 2023; 14:1201085.

PMID: 37292151 PMC: 10244546. DOI: 10.3389/fphar.2023.1201085.


Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification.

Zhi G, Shao B, Zheng T, Mu J, Li J, Feng Y Front Pharmacol. 2023; 14:1082451.

PMID: 36762105 PMC: 9902723. DOI: 10.3389/fphar.2023.1082451.


Alkaloids as potential antivirals. A comprehensive review.

Faisal S, Badshah S, Kubra B, Emwas A, Jaremko M Nat Prod Bioprospect. 2023; 13(1):4.

PMID: 36598588 PMC: 9812014. DOI: 10.1007/s13659-022-00366-9.


References
1.
Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2018; 47(D1):D1102-D1109. PMC: 6324075. DOI: 10.1093/nar/gky1033. View

2.
Ciesek S, von Hahn T, Colpitts C, Schang L, Friesland M, Steinmann J . The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology. 2011; 54(6):1947-55. DOI: 10.1002/hep.24610. View

3.
Irwin J, Sterling T, Mysinger M, Bolstad E, Coleman R . ZINC: a free tool to discover chemistry for biology. J Chem Inf Model. 2012; 52(7):1757-68. PMC: 3402020. DOI: 10.1021/ci3001277. View

4.
Zhang C, Freddolino L, Freddolino P, Zhang Y . COFACTOR: improved protein function prediction by combining structure, sequence and protein-protein interaction information. Nucleic Acids Res. 2017; 45(W1):W291-W299. PMC: 5793808. DOI: 10.1093/nar/gkx366. View

5.
Umamaheswari A, Kumar M, Pradhan D, Marisetty H . Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus. Interdiscip Sci. 2011; 3(1):64-77. DOI: 10.1007/s12539-011-0064-y. View